Email: Don.Curtis@ucsf.edu
Don Curtis is a professor in the Division of Prosthodontics at University of California San Francisco. He received his DMD from the University of Oregon and certificates in prosthodontics from USC and maxillofacial prosthodontics from UCLA (1985). Dr. Curtis has over 100 publications in peer reviewed journals including Head and Neck, Bone, Medical Education, and numerous other basic science, medical, and prosthodontic journals. Dr. Curtis is past president of the Pacific Coast Society for Prosthodontics and American Board of Prosthodontics. His research interests include evaluating bone strain around dental implants during wound healing and how bone implant contact is influenced by strain. Recent publications have focused on maintenance issues related to dental implants. Dr. Curtis is also involved in professional development and how clinicians accept feedback.
… among many others.
… among many others.
Topic
Checklist, Diagnostic Aids, and Guidelines
Description
This program will review how a risk assessment questionnaire (RAQ) can be used to estimate cumulative risk for late-term biologic complications related to implants. In private practice settings where this risk assessment tool has been used, patient acceptance and clinician feedback have been positive. Several ongoing clinical validation studies of the risk assessment algorithm will be reviewed in the context of how treatment planning and patient compliance can be improved. The goal is fewer unanticipated surprises for the clinician and fewer unexplained surprises for the patient.
Calculating aggregate risk for a health outcome allows risk to be stratified so that the unique risk profile of a patient is identified and managed. In medicine there are hundreds of risk assessment questionnaires that are used to provide an estimate of aggregate risk for a health outcome. This is the basis of personalized medicine.
The RAQ discussed includes a summary of 20 individual factors that can increase the risk for biologic complications in patients being treated with dental implants. It can serve as a checklist for the clinician, informed consent for the patient, and as a means by which to establish a patient-specific maintenance program.
Learning Objectives
At the end of the presentation, attendees will be able to:
Time
September 28th, 2022
6:30 PM ET to 8:30 PM ET (2 hours)
6:00 PM PT to 8:00 PM PT (2 hours)
CE Credits Offered for this Session: 2